Barinthus Biotherapeutics plc (BRNS) Tops Q1 EPS by 18c
Tweet
Share
E-mailGet Alerts BRNS Hot Sheet
Join SI Premium – FREE
Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q1 EPS of ($0.14), $0.18 better than the analyst estimate of ($0.32).
For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
- MiniMed Group (MMED) PT Raised to $28 at BTIG
- Morgan Stanley upgrades Robinhood, sees 43% upside
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
